You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1172433 |
---|---|
Category | Proteins |
Description | PD-1 - PD-L1 interaction blocker; Peptides. |
CAS Number | 1353563-85-5 |
C terminal amide, amide bridge between Lys-8 and Phe-7 in branch chain. | |
H-Ser-Asn-Thr-Ser-Glu-Ser-Phe-Lys(H-Ser-Asn-Thr-Ser-Glu-Ser-Phe)-Phe-Arg-Val-Thr-Gln-Leu-Ala-Pro-Lys-Ala-Gln-Ile-Lys-Glu-NH2 | |
Protein-protein interactions | |
Form/Appearance | Freeze dried solid |
Purity | > 95% by hplc |
MW | 3261.55 Da |
Formula | C142H226N40O48 |
Solubility (25°C) | Soluble in water |
Protein Sequence | H-Ser-Asn-Thr-Ser-Glu-Ser-Phe-Lys(H-Ser-Asn-Thr-Ser-Glu-Ser-Phe)-Phe-Arg-Val-Thr-Gln-Leu-Ala-Pro-Lys-Ala-Gln-Ile-Lys-Glu-NH2 |
Storage | Store dry, frozen and in the dark |
Alternative names | 1353563-85-5, AUNP 12, AUR 012, NP-12, NP12, PD-1- Read more... |
Background | NP-12 is a branched peptide designed from analysis of the strands and loops of programmed cell death protein 1 (PD-1) at the interface of the PD-1/ programmed cell death ligand 1 (PD-L1) interaction. NP-12 binds to PD-L1 and is a functional equipotent antagonist of both PD-L1 and PD-L2 signaling. In preclinical models of melanoma, coloncancer, and kidney cancers, NP-12 showed significant efficacyin inhibiting primary tumour growth and metastasis. NP-12 shows antitumour activity in pre-established tumour modelseither as a single agent or when in combination with other immunologic cell death agents. |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |